Farah Champsi

Farah Champsi is a partner at Population Health Partners, an investment firm focused on the life sciences. Previously, she was a venture capital investor at Alta Partners and at InterWest Partners as a managing director and general partner. She has raised more than $1 billion in venture funds, served on the boards of 14 public and private companies, and led investments in many premier biotechnology companies, including Kite Pharma (acquired by Gilead for $11.9 billion in 2017). She has a bachelor’s degree from Smith College and a master of business administration degree from Stanford University. She is a trustee of Smith College and Charles Armstrong School.